Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Becton Dickinson, Bionano, Yourgene, More

NEW YORK – Becton Dickinson, along with Heart to Heart International, the National Association of Free and Charitable Clinics, and Henry Schein Cares, said this week that it has awarded six free and charitable clinics in the US product-based grants worth a total of $360,000. The BD Point-of-Care, Enhancing Clinical Effectiveness (PoCECE) initiative will provide the clinics with lab equipment to evaluate patients and receive diagnostic test results while still on-site. The grants include a CLIA-waived test system and assays, as well as training and technical support. The recipients are the Agape Medical Clinic in Weatherford, Oklahoma; Esperanza Center in Baltimore, Maryland; La Clinica Gratis of Community Initiatives in Greenwood, South Carolina; Viola Startzman Clinic in Wooster, Ohio; Premier Mobile Health Services in Fort Meyers, Florida; and The Free Clinics in Hendersonville, North Carolina. 

Bionano Laboratories, a newly formed subsidiary of Bionano Genomics, announced a collaboration with OptraHealth this week to improve its customer testing experience by adopting OptraHealth’s AI-based HealthFax platform. With its new operational workflow, Bionano Laboratories said the platform will provide patients with information on the genetic testing process and testing options, as well as collect personal and family history to facilitate future potential discussions with genetic counselors. Bionano CEO Erik Holmlin said in a statement that the implementation of the platform will help Bionano Laboratories “scale as it expands services in the future.” 

British medical technology company TestCard announced this week that it has signed a collaboration contract with Roche to integrate its ClearScreen scanning technology with Roche’s Cobas Pulse point-of-care system. ClearScreen includes a mobile application that scans and analyzes test strips and a web solution that stores the results and can be integrated with an electronic medical record. The app will be available through the Cobas Pulse system in patient and hospital settings, TestCard said in a statement, and Roche’s Combur 10 UX Urinalysis Test Strips will be the first tests supported by the app. 

Yourgene Health said this week that it has received Health Science Authority (HAS) approval for its Iona Nx NIPT workflow in Singapore. The noninvasive prenatal screening workflow, which tests for trisomies 21, 18, and 13 and other chromosomal aneuploidies, is now authorized for use in clinical laboratories in this country. 

Angle said this week that it had £400,000 ($439,000) in revenues for the first half of 2022, up 33 percent from £300,000 a year ago. For the six months ended June 30, the UK firm posted a loss of £9.2 million compared to a loss of £7.7 million a year ago, which it said reflected planned investment. Angle exited H1 2022 with £20.5 million in cash and cash equivalents and raised an additional £18.9 million in net proceeds since then. 

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on 360Dx.